[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0016168A - Therapeutic combinations of (s) -2- (benzylaminomethyl) -2,3,8,9tetrahydro-7h-1,4-dioxy in [2,3 -e] indol-8-one and neuroleptics for the treatment or prevention of disorders psychotic - Google Patents

Therapeutic combinations of (s) -2- (benzylaminomethyl) -2,3,8,9tetrahydro-7h-1,4-dioxy in [2,3 -e] indol-8-one and neuroleptics for the treatment or prevention of disorders psychotic

Info

Publication number
BR0016168A
BR0016168A BR0016168-3A BR0016168A BR0016168A BR 0016168 A BR0016168 A BR 0016168A BR 0016168 A BR0016168 A BR 0016168A BR 0016168 A BR0016168 A BR 0016168A
Authority
BR
Brazil
Prior art keywords
prevention
treatment
neuroleptics
therapeutic combinations
benzylaminomethyl
Prior art date
Application number
BR0016168-3A
Other languages
Portuguese (pt)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR0016168A publication Critical patent/BR0016168A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMBINAçõES TERAPêUTICAS DE (S)-2(BENZILAMINOMETIL)-2,3,8,9-TETRAHIDRO-7H-1,4-DIOXI NO[2,3 -e] IN-DOL-8-ONA E NEUROLéPTICOS PARA O TRATAMENTO OU PREVENçãO DE DISTúRBIOS PSICóTICOS". São fornecidas combinações terapêuticas úteis no tratamento ou prevenção de distúrbios psicóticos, para composições farmacêuticas contendo as combinações e para uso no tratamento ou profilaxia de prevenção de distúrbios."THERAPEUTIC COMBINATIONS OF (S) -2 (BENZYLAMINOMETHIL) -2,3,8,9-TETRAHYDRO-7H-1,4-DIOXI IN [2,3 -e] IN-DOL-8-ONA AND NEUROLEPTICS FOR TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS ". Therapeutic combinations useful in the treatment or prevention of psychotic disorders are provided, for pharmaceutical compositions containing the combinations and for use in the treatment or prevention prophylaxis of disorders.

BR0016168-3A 1999-12-10 2000-12-07 Therapeutic combinations of (s) -2- (benzylaminomethyl) -2,3,8,9tetrahydro-7h-1,4-dioxy in [2,3 -e] indol-8-one and neuroleptics for the treatment or prevention of disorders psychotic BR0016168A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45860799A 1999-12-10 1999-12-10
PCT/US2000/033060 WO2001041750A2 (en) 1999-12-10 2000-12-07 Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics

Publications (1)

Publication Number Publication Date
BR0016168A true BR0016168A (en) 2002-08-20

Family

ID=23821437

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016168-3A BR0016168A (en) 1999-12-10 2000-12-07 Therapeutic combinations of (s) -2- (benzylaminomethyl) -2,3,8,9tetrahydro-7h-1,4-dioxy in [2,3 -e] indol-8-one and neuroleptics for the treatment or prevention of disorders psychotic

Country Status (20)

Country Link
EP (1) EP1235570A2 (en)
JP (1) JP5557409B2 (en)
KR (1) KR100772854B1 (en)
CN (1) CN1230164C (en)
AR (1) AR026756A1 (en)
AU (1) AU784211B2 (en)
BR (1) BR0016168A (en)
CA (1) CA2396351C (en)
CZ (1) CZ20021880A3 (en)
EA (1) EA005002B1 (en)
HK (1) HK1045942A1 (en)
HU (1) HUP0203309A3 (en)
IL (2) IL149669A0 (en)
MX (1) MXPA02005649A (en)
NO (1) NO20022739D0 (en)
NZ (1) NZ519381A (en)
PL (1) PL355292A1 (en)
TW (1) TWI222864B (en)
WO (1) WO2001041750A2 (en)
ZA (1) ZA200205484B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050095292A1 (en) 2003-10-29 2005-05-05 Wyeth Sustained release pharmaceutical compositions
BRPI0608353A2 (en) 2005-02-17 2009-12-01 Wyeth Corp indole, benzothiophene, benzofuran and indene cycloalkyl fused derivatives
ES2430622T3 (en) * 2008-02-13 2013-11-21 Targacept, Inc. Combination of alpha 7 nicotinic and antipsychotic agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2987484B2 (en) * 1995-03-16 1999-12-06 大塚製薬 株式会社 Method for producing carbostyril derivative
US5756532A (en) * 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
CN1409633A (en) 2003-04-09
IL149669A0 (en) 2002-11-10
JP2003516350A (en) 2003-05-13
CZ20021880A3 (en) 2002-08-14
WO2001041750A2 (en) 2001-06-14
EP1235570A2 (en) 2002-09-04
NO20022739L (en) 2002-06-07
WO2001041750A3 (en) 2002-02-14
CN1230164C (en) 2005-12-07
IL149669A (en) 2006-06-11
TWI222864B (en) 2004-11-01
ZA200205484B (en) 2003-12-31
EA005002B1 (en) 2004-10-28
NO20022739D0 (en) 2002-06-07
AU1949001A (en) 2001-06-18
HK1045942A1 (en) 2002-12-20
EA200200656A1 (en) 2002-12-26
MXPA02005649A (en) 2004-09-10
CA2396351A1 (en) 2001-06-14
AR026756A1 (en) 2003-02-26
PL355292A1 (en) 2004-04-05
HUP0203309A2 (en) 2003-01-28
KR100772854B1 (en) 2007-11-02
HUP0203309A3 (en) 2004-12-28
KR20030016207A (en) 2003-02-26
NZ519381A (en) 2004-04-30
AU784211B2 (en) 2006-02-23
CA2396351C (en) 2009-11-10
JP5557409B2 (en) 2014-07-23

Similar Documents

Publication Publication Date Title
HK1056683A1 (en) New pharmaceutical composition
ATE231872T1 (en) THIAZOLOPYRIMIDE DERIVATIVES
ATE350377T1 (en) SUBSTITUTED 3-PYRROLIDINE INDOLE DERIVATIVES
BR0015416A (en) Compositions containing tetraenoic hydroxyieic acid derivatives and methods of use in the treatment of dry eye disorders
BR0316296A (en) Lapacone compounds and their methods of use
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
TR200200716T2 (en) Quetiapine granules
CA2284551A1 (en) New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders
SE9802208D0 (en) Novel compounds
YU13301A (en) Muscarinic agonists and antagonists
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
DE60202590D1 (en) 2H-1-BENZOPYRANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
SE9802209D0 (en) Novel compounds
ES2175356T3 (en) USE OF (+) - ALPHA- (2,3-DIMETOXIFENIL) -1- [2- (4 FLUOROFENIL) ET IL [-4- PIPERIDINMETANOL IN THE TREATMENT OF DEPRESSIVE DISORDERS AND BIPOLAR DISORDERS.
SE0001916D0 (en) Novel formulation
BR0016168A (en) Therapeutic combinations of (s) -2- (benzylaminomethyl) -2,3,8,9tetrahydro-7h-1,4-dioxy in [2,3 -e] indol-8-one and neuroleptics for the treatment or prevention of disorders psychotic
DK0916670T3 (en) Pyrrolo [3,2-b] pyridines and their use as 5-HT1f agonists
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
MY133682A (en) Substituted pyrroles
ITTO20000441A0 (en) THERAPEUTIC COMPOSITION FOR THE TREATMENT OF PSORIASIS.
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
DE60003074D1 (en) Fusidic DERIVATIVES
WO1999019324A3 (en) Antipsychotic substituted piperidine derivatives
WO2003040119A8 (en) Angiogenesis inhibitors

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10, 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]